Key Takeaways
- • Vocca raised a $20M Series A led by Norrsken VC, with participation from Heal Capital, Speedinvest and Firstminute Capital.
- • The company's AI phone assistant, which automates patient calls, now serves 15,000 medical practitioners, up from 2,000 a year earlier.
- • Vocca operates across 1,500 practices and twenty medical specialties in the US and Europe.
- • Monthly conversation volume grew 10x to more than one million, while revenue grew 7x over the same twelve-month period.
Summary
Vocca has announced a $20M Series A funding round led by Norrsken VC, with participation from Heal Capital, Speedinvest and Firstminute Capital. The company, based in New York, is positioning its AI phone assistant as a tool for automating patient communications in healthcare settings.
Vocca's flagship product handles patient calls on behalf of medical practices. According to the company's announcement, the number of medical practitioners using the platform has risen from approximately 2,000 a year ago to 15,000 today. Usage now spans 1,500 practices across twenty medical specialties in the United States and Europe.
Operating metrics have grown alongside the user base. Conversation volume increased tenfold over the same period, surpassing one million conversations per month. Revenue grew sevenfold over the same twelve-month window, indicating that growth in customer adoption has translated into commercial scale.
The round positions Vocca to expand its footprint in the US and Europe as demand for automated patient-facing communications increases. The company did not disclose a valuation in the announcement.
Vocca's flagship product handles patient calls on behalf of medical practices. According to the company's announcement, the number of medical practitioners using the platform has risen from approximately 2,000 a year ago to 15,000 today. Usage now spans 1,500 practices across twenty medical specialties in the United States and Europe.
Operating metrics have grown alongside the user base. Conversation volume increased tenfold over the same period, surpassing one million conversations per month. Revenue grew sevenfold over the same twelve-month window, indicating that growth in customer adoption has translated into commercial scale.
The round positions Vocca to expand its footprint in the US and Europe as demand for automated patient-facing communications increases. The company did not disclose a valuation in the announcement.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.